S-ClassAbout S-Class
H
HOWLAI Stock Diagnostic Report
Werewolf Therapeutics to merge with Ambros in $150m deal
Werewolf Therapeutics has entered into a merger with Ambros valued at $150 million.
View Source Article ↗AI CATALYST SCORE85 / 100Score computed by Sentinel V12
REFERENCE PRICE$0.4309999942779541Reference entry price at analysis time
01
MARKET SNAPSHOT
Key Indicators at a Glance
Major Support0.34
Near-Term Resistance0.54
02
FUNDAMENTALS
Financial & Fundamental Analysis
The announcement of a $150 million merger (M&A) between Werewolf Therapeutics and Ambros will bring significant changes to the capital structure and corporate value; however, the lack of financial details limits the assessment of short-term financial impacts.
03
TECHNICAL VIEW
Technical Position & Response Criteria
The current price of $0.43 is positioned between the 20-day low support level ($0.34) and the high resistance level ($0.54), with an RSI of 76 indicating that it has entered overbought territory and is experiencing a significant correction on the day.
Support0.34
Resistance0.54
04
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
The $150 million merger and acquisition news is classified as a one-time external event beyond the company's control, and it is distant from the company-led business plans or production targets that may be sustained and repeated in the future.
05
PROOF OF WORK
Analysis Point vs. Subsequent Price Action
INITIAL · At Analysis (2026-08-21)
FINAL · Current/Verified
Renders the actual stored OHLC data directly in your browser.